Detalhe da pesquisa
1.
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies.
Oncologist
; 23(2): 159-170, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29118268
2.
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
BMC Cancer
; 16: 652, 2016 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27538433
3.
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
Oncologist
; 14(9): 862-70, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19726453
4.
Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States.
BMJ Open
; 8(7): e019955, 2018 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30037860
5.
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.
Oncotarget
; 8(47): 81926-81935, 2017 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29137233
6.
Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash.
Ther Clin Risk Manag
; 11: 1355-60, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26379438
7.
The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q).
Blood Cancer J
; 8(10): 90, 2018 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291223
8.
p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase.
PLoS One
; 5(5): e10486, 2010 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20463968
9.
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).
J Clin Oncol
; 26(33): 5326-34, 2008 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18854571